Follicular lymphoma grade III, unspecified, unspecified site
ICD-10 C82.20 is a billable code used to indicate a diagnosis of follicular lymphoma grade iii, unspecified, unspecified site.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade III indicates a more aggressive form of the disease, with a higher proliferation index and a greater likelihood of transformation to a more aggressive lymphoma. This code is used when the specific site of the lymphoma is not documented, which can complicate treatment planning and prognosis. Patients may present with B-symptoms such as fever, night sweats, and weight loss, which are indicative of systemic involvement. Staging of follicular lymphoma is crucial for determining treatment options, which may include watchful waiting, chemotherapy, immunotherapy, or stem cell transplantation, depending on the stage and symptoms. Accurate coding is essential for appropriate reimbursement and treatment planning.
Detailed clinical notes on symptoms, staging, and treatment plans.
Diagnosis of follicular lymphoma, treatment planning, and follow-up care.
Ensure clear documentation of grade and symptoms to support coding.
Pathology reports must specify grade and histological findings.
Biopsy interpretation and grading of lymphomas.
Accurate histological classification is critical for coding.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists must ensure accurate coding of treatment.
B-symptoms include fever, night sweats, and unexplained weight loss, which can indicate more advanced disease and influence treatment decisions.
